Details for New Drug Application (NDA): 207582
✉ Email this page to a colleague
The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for 207582
Tradename: | PERPHENAZINE |
Applicant: | Watson Labs Inc |
Ingredient: | perphenazine |
Patents: | 0 |
Suppliers and Packaging for NDA: 207582
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PERPHENAZINE | perphenazine | TABLET;ORAL | 207582 | ANDA | Actavis Pharma, Inc. | 0591-4101 | 0591-4101-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0591-4101-01) |
PERPHENAZINE | perphenazine | TABLET;ORAL | 207582 | ANDA | Actavis Pharma, Inc. | 0591-4102 | 0591-4102-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0591-4102-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Oct 17, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
Approval Date: | Oct 17, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 8MG | ||||
Approval Date: | Oct 17, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription